Expertise in
4
conditions

Aaron D. Schimmer

Toronto, ON, CA 
Expertise in
4
conditions
Toronto, ON, CA 

Overview

Aaron Schimmer practices practicing medicine in Toronto, Canada.

Mr. Schimmer is highly rated in 4 conditions, according to our data. His clinical expertise encompasses Leukemia, Acute Myeloid Leukemia (AML), Acute Lymphoblastic Leukemia (ALL), Myeloproliferative Neoplasms (MPN), and Bone Marrow Transplant.

He is actively involved in clinical research, co-authoring 223 peer reviewed articles and participating in 3 clinical trials.

Gender

Male

Locations

Toronto, ON, Canada
Other Locations
Toronto, Canada

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

A Phase 1 Dose-Escalation Study of AEB1102 (Co-ArgI-PEG) in Patients With Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Syndrome Refractory to Hypomethylating Agents
A Phase 1 Dose-Escalation Study of AEB1102 (Co-ArgI-PEG) in Patients With Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Syndrome Refractory to Hypomethylating Agents
Enrollment Status: Completed
Publish Date: August 13, 2026
Intervention Type: Drug
Study Phase: Phase 1
Randomized Phase II Study to Assess the Role of Nivolumab as Single Agent to Eliminate Minimal Residual Disease and Maintain Remission in Acute Myelogenous Leukemia (AML) Patients After Chemotherapy (REMAIN TRIAL)
Randomized Phase II Study to Assess the Role of Nivolumab as Single Agent to Eliminate Minimal Residual Disease and Maintain Remission in Acute Myelogenous Leukemia (AML) Patients After Chemotherapy (REMAIN TRIAL)
Enrollment Status: Active_not_recruiting
Publish Date: May 28, 2026
Intervention Type: Procedure, Biological, Other
Study Drug: Nivolumab
Study Phase: Phase 2
Identification of Patients With Age-Related Clonal Hematopoiesis (ARCH) Among Cancer Survivors.
Identification of Patients With Age-Related Clonal Hematopoiesis (ARCH) Among Cancer Survivors.
Enrollment Status: Active_not_recruiting
Publish Date: February 03, 2025
Intervention Type: Other
View 2 Less Clinical Trials

223 Total Publications

Elevated mitochondrial protein import in acute myeloid leukemia increases reliance on mitochondrial protease LONP1.
Elevated mitochondrial protein import in acute myeloid leukemia increases reliance on mitochondrial protease LONP1.
Journal: The Journal of clinical investigation
Published: June 16, 2026

Frequently Asked Questions about Aaron D. Schimmer

Is Aaron D. Schimmer a top-rated expert for Leukemia?

MediFind is an objective health platform that identifies experts based on real-world data. Aaron D. Schimmer is classified as an Elite expert for Leukemia, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Aaron D. Schimmer participate in research or clinical trials?

Yes. Aaron D. Schimmer has published 223 articles and abstracts on conditions like Leukemia. You can view a list of Aaron D. Schimmer's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Schimmer's expertise for a condition
ConditionClose
    View All 16 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile